12 completed, 1 terminated. 10 Phase 3, 2 Phase 2, 1 Phase 1.
By phase and status
Follow taspoglutide: new trials by email Literature Review of taspoglutide trials Research Report on taspoglutide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
placebo, taspoglutide - Diabetes Mellitus Type 2 | Phase 3 | Completed | 2118 | 2010-01-01 | 2016-11-02 |
A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy
insulin glargine, metformin, taspoglutide - Diabetes Mellitus Type 2 | Phase 3 | Terminated | 370 | 2010-01-01 | 2016-11-02 |
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
pioglitazone, taspoglutide - Diabetes Mellitus Type 2 | Phase 3 | Completed | 756 | 2009-05-01 | 2016-11-02 |
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
placebo, taspoglutide - Diabetes Mellitus Type 2 | Phase 3 | Completed | 305 | 2009-01-01 | 2016-07-28 |
A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes
Placebo, taspoglutide - Diabetes Mellitus Type 2 | Phase 3 | Completed | 60 | 2008-12-01 | 2016-11-02 |
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
insulin glargine, metformin, taspoglutide - Diabetes Mellitus Type 2 | Phase 3 | Completed | 1072 | 2008-11-01 | 2016-07-29 |
A Study of Taspoglutide in Type 2 Diabetic Patients
Placebo, taspoglutide - Diabetes Mellitus Type 2 | Phase 1 | Completed | 18 | 2008-11-01 | 2016-11-02 |
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
Metformin, Placebo (matching sitagliptin), Placebo (matching taspoglutide) - Diabetes Mellitus Type 2 | Phase 3 | Completed | 666 | 2008-10-01 | 2016-11-04 |
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
metformin, pioglitazone, placebo - Diabetes Mellitus Type 2 | Phase 3 | Completed | 326 | 2008-10-01 | 2016-08-05 |
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
placebo, taspoglutide - Diabetes Mellitus Type 2 | Phase 3 | Completed | 373 | 2008-08-01 | 2016-07-28 |
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
exenatide, taspoglutide - Diabetes Mellitus Type 2 | Phase 3 | Completed | 1189 | 2008-07-01 | 2016-11-02 |
A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Placebo, Taspoglutide 20mg, Taspoglutide 20mg-30mg - Diabetes Mellitus Type 2 | Phase 2 | Completed | 133 | 2007-04-01 | 2016-11-02 |
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Placebo, taspoglutide - Diabetes Mellitus Type 2 | Phase 2 | Completed | 306 | 2007-02-01 | 2016-11-02 |
Conditions studied
Diabetes Mellitus, Type 2 (13)
Sponsors
Hoffmann-La Roche (13)
Countries
Germany (11) · United States (10) · Mexico (9) · Australia (8) · Canada (7) · Puerto Rico (7) · United Kingdom (7) · France (6) · Peru (6) · Russia (6) · Spain (6) · Thailand (6) · Brazil (5) · Guatemala (5) · Poland (5)
Results publications
PMID 19366970, PMID 20536952, PMID 22937895, PMID 23139373
NIH funding
2008 (8), 2009 (2)